Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Race Oncology Ltd. ( (AU:RAC) ) has provided an announcement.
Race Oncology Ltd has announced the quotation of 3,300 fully paid ordinary securities on the ASX, effective June 26, 2025. This move signifies the company’s ongoing efforts to enhance its market presence and potentially attract more investors, reflecting its strategic focus on expanding its operational capabilities within the oncology sector.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 126,842
Technical Sentiment Signal: Sell
Current Market Cap: A$223.3M
For an in-depth examination of RAC stock, go to TipRanks’ Overview page.